140 related articles for article (PubMed ID: 3121397)
1. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
Wajchenberg BL; Achando SS; Mathor MM; Czeresnia CE; Giannella Neto D; Kirschner MA
Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
[TBL] [Abstract][Full Text] [Related]
2. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
3. Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone.
Parker CR; Bruneteau DW; Greenblatt RB; Mahesh VB
Fertil Steril; 1975 Sep; 26(9):877-88. PubMed ID: 126875
[TBL] [Abstract][Full Text] [Related]
4. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease.
DeVane GW; Czekala NM; Judd HL; Yen SS
Am J Obstet Gynecol; 1975 Feb; 121(4):496-500. PubMed ID: 125040
[TBL] [Abstract][Full Text] [Related]
5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
6. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
7. Ovarian and adrenal contribuion to peripheral steroids during the menstrual cycle in two hirsute women.
Abraham GE
Obstet Gynecol; 1975 Jul; 46(1):29-36. PubMed ID: 1153134
[No Abstract] [Full Text] [Related]
8. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
9. Altered androstenedione and estrone dynamics associated with abnormal hormonal profiles in amenorrheic subjects with weight loss or obesity.
Loughlin T; Cunningham SK; Culliton M; Smyth PP; Meagher DJ; McKenna TJ
Fertil Steril; 1985 May; 43(5):720-5. PubMed ID: 3888679
[TBL] [Abstract][Full Text] [Related]
10. Androgen and estrogen formation in women with ovarian hyperthecosis.
Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
12. Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
Lucisano A; Acampora MG; Russo N; Maniccia E; Montemurro A; Dell'Acqua S
Maturitas; 1984 Jul; 6(1):45-53. PubMed ID: 6472127
[TBL] [Abstract][Full Text] [Related]
13. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
[TBL] [Abstract][Full Text] [Related]
14. Ovarian androgen production in postmenopausal women.
Fogle RH; Stanczyk FZ; Zhang X; Paulson RJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3040-3. PubMed ID: 17519304
[TBL] [Abstract][Full Text] [Related]
15. Plasma hormone profile in anovulation.
Wu CH; Mikhail G
Fertil Steril; 1979 Mar; 31(3):258-66. PubMed ID: 571358
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
17. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
Gonzalez F; Hatala DA; Speroff L
Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
[TBL] [Abstract][Full Text] [Related]
18. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
Hudson RW; Lochnan HA; Danby FW; Margesson LJ; Strang BK; Kimmett SM
Fertil Steril; 1990 Dec; 54(6):1065-71. PubMed ID: 2174005
[TBL] [Abstract][Full Text] [Related]
19. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
BidziĆska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
20. Adrenal and ovarian steroid secretion in the rat estrous cycle temporally related to gonadotropins and steroid levels found in peripheral plasma.
Shaikh AA; Shaikh SA
Endocrinology; 1975 Jan; 96(1):37-44. PubMed ID: 1167355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]